Executive Briefing Series (formerly The Food & Drug Letter)
May 4, 2012
High Vigilance Drugs Now Required to Display ‘Black Symbol’ in Labeling
For the first time, high-risk drugs subject to special monitoring must carry a “black symbol” in the product labeling.
This article is viewable by subscribers only. To view this article, please select an option below.
|